Agents in development for the treatment of hepatitis C. Summary and table.
Dunn
C
C
Adis International Limited, Auckland, New Zealand.
Wilde
M
M
Paterson
R
R
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D011994:Recombinant Proteins; D014765:Viral Vaccines; D007372:Interferons